EDN1 and chronic kidney disease: The mechanisms of ET-1 action in the pathology of chronic kidney disease (CKD) involve increased cell proliferation, inflammation, and elaboration of the extracellular matrix (Speed and Pollock, 2013; Kohan and Barton, 2014; Reichetzeder et al., 2014).